The company inked a major pharma deal with Indian pharmaceutical manufacturer Laurus Labs in May, citing it as a key driver of growth. Willow Biosciences Inc....
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) told investors it was changing its name to Quantum BioPharma Ltd. and consolidating shares. The company didn’t give a...
A pair of cannabis trade organizations in California that represent hundreds of small businesses held a press conference on Thursday to sound the alarm over a...
Lykos Therapeutics hit a major roadblock Friday in its bid to bring the first psychedelic-based therapy for post-traumatic stress disorder to market, as U.S. regulators rejected...
Monko is a lifestyle cannabis dispensary in Washington D.C. Owner and Chief Executive Officer Terrence White told Green Market Report about his transition from an I-71...
The company plans to use the funds for research and development on its psychedelic treatments for anxiety. New York-based Mind Medicine (Nasdaq: MNMD) announced a new...
Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC) announced its financial results for the first fiscal 2025 quarter ending June 30, 2024. Canopy’s total revenue fell by...
After markets closed on Wednesday, Relmada Therapeutics, Inc. (Nasdaq: RLMD) delivered its financial results for the second quarter ending June 30, 2024. The company does not...
Cannabis technology firm says performance was dragged down by its Jupiter hardware division. TILT Holdings Inc. (OTCQB: TLLTF) saw a steeper loss and sharply lower revenue...
This article has been updated. TerrAscend Corp. (TSX: TSND)(OTCQX: TSNDF) delivered solid financial results for the second quarter ending June 30, with revenue up 7.5% to...